18.10.2013 • NewsBASFBraskemBrazil

Styrolution and Braskem in Brazilian Styrenics JV

Styrolution, the Frankfurt, Germany-based styrenics joint venture of BASF and Ineos, has signed a memorandum of understanding (MoU) with Brazilian plastics giant Braskem on a 100,000 t/y plant for styrenics specialties and copolymers ABS and SAN to be built in Brazil and pencilled in to go on stream in 2017.

The facility, which the partners claim would be the sole producer of ABS and SAN specialities, in South America, would supply customers in the South American household appliances and automotive sectors. It is planned to be operated by a 70:30 joint venture majority owned by Styrolution, with the German company contributing its technology and polymers portfolio, with the Brazilian partner providing knowledge of the local and regional markets, supply chain infrastructure and as yet undisclosed site for the project.

Building on Styrolution's recently announced strategy to expand its footprint in emerging markets, grow its specialty styrenics business and focus on select, higher-growth industries, the proposed jv "ticks all the boxes," said CEO Roberto Gualdoni. 

The partnership would be an important step towards strengthening the petrochemical sector in Brazil, said Braskem CEO Carlos Fadigas, adding that it would create opportunities for the country to gain independence from imports in markets such as ABS.

 

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.